An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

類似資料

• Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala
  著者:: Laker, Eva, 等
  出版事項: (2014)
• Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
  著者:: Broder, MS, 等
  出版事項: (2010)
• Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen
  著者:: von Hentig, Nils, 等
  出版事項: (2007)
• Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
  著者:: Ganesan, Anuradha, 等
  出版事項: (2009)
• Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients.
  著者:: Takeshi Nishijima, 等
  出版事項: (2013-01-01)